Caractéristiques cliniques et réponse thérapeutique de la granulomatose oro-faciale
M. Dumas(Hôpital Cochin), Jean‐David Bouaziz(Université Paris Cité), Martine Bagot(Université Paris Cité), M. Jachiet(Assistance Publique – Hôpitaux de Paris), F. Henrion-Charbit(Inserm), M. Rybojad(Hôpital Saint-Louis), A. Petit(Hôpital Saint-Louis), F. Cordoliani(Assistance Publique – Hôpitaux de Paris), Georgia Malamut(Délégation Paris 5), F. Pascal(Hôpital Saint-Louis), A. Flavant(Hôpital Saint-Louis), Nadine Cerf–Bensussan(Université Paris Cité)
Cited by 0
Related Papers
A Regulatory B Cell Subset with a Unique CD1dhiCD5+ Phenotype Controls T Cell-Dependent Inflammatory Responses
|Immunity|2008|1.2k
Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression
|Journal of Clinical Investigation|2008|907
Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease
|Gastroenterology|2003|457
Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients*
|British Journal of Dermatology|2021|414
Presentation and Long-Term Follow-up of Refractory Celiac Disease: Comparison of Type I With Type II
|Gastroenterology|2008|378